Endogenous nitric oxide synthase inhibitor as a novel marker of atherosclerosis in humans

被引:0
|
作者
Miyazaki, H [1 ]
Matsuoka, H [1 ]
Usui, M [1 ]
Ueda, S [1 ]
Okuda, S [1 ]
Imaizumi, T [1 ]
机构
[1] Kurume Univ, Sch Med, Dept Internal Med 3, Kurume, Fukuoka 830, Japan
关键词
D O I
暂无
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
P1108
引用
收藏
页码:S87 / S87
页数:1
相关论文
共 50 条
  • [21] An endogenous inhibitor of nitric oxide synthase regulates endothelial adhesiveness for monocytes
    Böger, RH
    Bode-Böger, SM
    Tsao, PS
    Lin, PS
    Chan, JR
    Cooke, JP
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 36 (07) : 2287 - 2295
  • [22] Elevation of an endogenous inhibitor of nitric oxide synthase in diabetic rat serum
    Xiong, Y
    Lu, R
    Li, YJ
    Deng, HW
    ACTA PHARMACOLOGICA SINICA, 1997, 18 (06): : 511 - 514
  • [23] Role of endogenous nitric oxide synthase inhibitor in gastric mucosal injury
    Wang, Li
    Zhou, Yuan
    Peng, Jun
    Zhang, Zhe
    Jiang, De-Jian
    Li, Yuan-Jian
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2008, 86 (03) : 97 - 104
  • [24] The Effect of a Neuronal Nitric Oxide Synthase Inhibitor on Neurovascular Regulation in Humans
    O'Gallagher, Kevin
    Rosentreter, Ryan E.
    Soriano, Jan Elaine
    Roomi, Ali
    Saleem, Saqib
    Lam, Tyler
    Roy, Roman
    Gordon, Grant R.
    Raj, Satish R.
    Chowienczyk, Philip J.
    Shah, Ajay M.
    Phillips, Aaron A.
    CIRCULATION RESEARCH, 2022, 131 (12) : 952 - 961
  • [25] EFFECTS OF A NITRIC-OXIDE SYNTHASE INHIBITOR IN HUMANS WITH SEPTIC SHOCK
    PETROS, A
    LAMB, G
    LEONE, A
    MONCADA, S
    BENNETT, D
    VALLANCE, P
    CARDIOVASCULAR RESEARCH, 1994, 28 (01) : 34 - 39
  • [26] Asymmetric dimethylarginine (ADMA), an endogenous inhibitor of nitric oxide synthase, acts as a novel cardiovascular risk factor
    Böger, R. H.
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 22 - 23
  • [27] Nitric oxide synthase inhibitor
    Lloyd, AW
    DRUG DISCOVERY TODAY, 2000, 5 (02) : 86 - 86
  • [28] Inducible nitric oxide synthase and atherosclerosis
    Ikeda, U
    Maeda, Y
    Shimada, K
    CLINICAL CARDIOLOGY, 1998, 21 (07) : 473 - 476
  • [29] Cardiovascular effects of the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine (ADMA) and evidence for ADMA metabolism in humans in vivo
    Achan, V
    Broadhead, M
    Malaki, M
    Leiper, J
    MacAllister, R
    Vallance, P
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (06) : 303A - 303A
  • [30] Induction of nitric oxide synthase in humans, in vivo; Endothelial nitric oxide synthase masquerading as inducible nitric oxide synthase
    Bhagat, K
    Vallance, PJ
    CIRCULATION, 1997, 96 (08) : 4069 - 4069